Abstract
Avidity-Engineered CD3 Engaging DARPin ® Targeting Three Tumor Associated Antigens Induce Strong and Specific T Cell Dependent Killing of AML Cells with Potential for Improved Safety
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have